BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25695577)

  • 1. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
    Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X4: A fast and sensitive purinergic receptor.
    Suurväli J; Boudinot P; Kanellopoulos J; Rüütel Boudinot S
    Biomed J; 2017 Oct; 40(5):245-256. PubMed ID: 29179879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.
    Al-Aqtash R; Collier DM
    Channels (Austin); 2024 Dec; 18(1):2355150. PubMed ID: 38762911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?
    Witkin JM; Shafique H; Smith JL; Cerne R
    Biochem Pharmacol; 2024 Apr; 222():116046. PubMed ID: 38341001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.
    Dal Ben D; Marchenkova A; Thomas A; Lambertucci C; Spinaci A; Marucci G; Nistri A; Volpini R
    Purinergic Signal; 2017 Mar; 13(1):61-74. PubMed ID: 27757785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1.
    Wang J; Jackson DG; Dahl G
    J Gen Physiol; 2013 May; 141(5):649-56. PubMed ID: 23589583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural compounds with P2X7 receptor-modulating properties.
    Fischer W; Urban N; Immig K; Franke H; Schaefer M
    Purinergic Signal; 2014; 10(2):313-26. PubMed ID: 24163006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central sensitization of nociceptive neurons in rat medullary dorsal horn involves purinergic P2X7 receptors.
    Itoh K; Chiang CY; Li Z; Lee JC; Dostrovsky JO; Sessle BJ
    Neuroscience; 2011 Sep; 192():721-31. PubMed ID: 21763757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
    Volonté C; Amadio S
    Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging the ATP-P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications.
    Yin Y; Wei L; Caseley EA; Lopez-Charcas O; Wei Y; Li D; Muench SP; Roger S; Wang L; Jiang LH
    Med Res Rev; 2023 Sep; 43(5):1346-1373. PubMed ID: 36924449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.
    Nörenberg W; Hempel C; Urban N; Sobottka H; Illes P; Schaefer M
    J Biol Chem; 2011 Apr; 286(13):11067-81. PubMed ID: 21262970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
    De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
    Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved residue in the P2X4 receptor has a nonconserved function in ATP recognition.
    Chen PF; Ma XF; Sun LF; Tian Y; Fan YZ; Li P; Xiao Z; Zhu MX; Guo CR; Li C; Yu Y; Wang J
    J Biol Chem; 2021; 296():100655. PubMed ID: 33901491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
    Allsopp RC; Dayl S; Schmid R; Evans RJ
    Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder.
    Svennersten K; Hallén-Grufman K; de Verdier PJ; Wiklund NP; Poljakovic M
    BMC Urol; 2015 Aug; 15():81. PubMed ID: 26253104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an assay for P2X7 receptor-mediated cell death.
    Lee SY; Jo S; Lee GE; Jeong LS; Kim YC; Park CS
    Mol Cells; 2006 Oct; 22(2):198-202. PubMed ID: 17085972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate physical exercise and ATP modulate the P2X7 receptor and improve cisplatin-induced gastric emptying delay in rats.
    Gomes YA; Santos WLL; Pinheiro CS; Severo JS; Oliveira Júnior JCC; da Silva ACA; Dos Santos BLB; Rocha CHL; Dos Santos AA; da Silva MTB
    Braz J Med Biol Res; 2024; 57():e13234. PubMed ID: 38716980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X receptor channels in chronic pain pathways.
    Bernier LP; Ase AR; Séguéla P
    Br J Pharmacol; 2018 Jun; 175(12):2219-2230. PubMed ID: 28728214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geoffery Burnstock's influence on the evolution of P2X3 receptor pharmacology.
    Jarvis MF
    Purinergic Signal; 2021 Mar; 17(1):33-39. PubMed ID: 33029713
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human.
    Tewari M; Michalski S; Egan TM
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.